EUVIMEDEUVIMED entdecken
Open Access

Restoring lung renin-angiotensin system balance through blood pressure control

Gabriela Catão D Braga, Joao Carlos Ribeiro-Silva, Andreia Boaro, Flavia Leticia Martins, Thais Mauad, Caio A M Tavares, Lisete Ribeiro Teixeira, Bruno Caramelli, Adriana C C Girardi iD

Clinical Science · 12.02.2025 · 139 (03) · 215-227

DOI: 10.1042/cs20241155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, online erschienen am 04.02.2025. Verfasst von Gabriela Catão D Braga und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Genética e Cardiologia Molecular, Faculdade de Medicina, Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, Universidade de …. Hauptthemen laut MEDLINE: Renin-Angiotensin System, Lung, Losartan, Blood Pressure. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulated renin-angiotensin system (RAS) signaling contributes to elevated blood pressure (BP), inflammation, and organ damage in systemic arterial hypertension (HTN). We have demonstrated that hypertensive humans and rats exhibit higher expression of classic RAS components and lower expression of counterregulatory RAS components in the lungs compared with normotensive counterparts. Here, we investigated whether BP control could restore the balance between classic [angiotensin I-converting enzyme 2 (ACE)/angiotensin II (Ang II)] and counterregulatory [angiotensin I-converting enzyme 2 (ACE2)/Ang (1-7)] RAS, thereby mitigating lung inflammation. Male spontaneously hypertensive rats (SHRs) were treated with either losartan or amlodipine, both of which effectively reduced BP. These interventions up-regulated lung Ace2 and down-regulated Ace gene expression. Pulmonary membrane ACE2 abundance and activity were higher in losartan- and amlodipine-treated SHRs than in vehicle-treated SHRs, whereas ACE protein and function remained unchanged. Drug-treated SHRs exhibited lower levels of lung Ang II and higher levels of Ang (1-7) than vehicle-treated SHRs. Rebalancing the pulmonary RAS remarkably reduced macrophage number and down-regulated pro-inflammatory genes in SHR lungs, with lower expression of lung pro-inflammatory genes correlating with lower circulating levels of ACE2. Serum analysis in healthy and hypertensive individuals supported these findings, showing higher ACE2 levels in uncontrolled compared with controlled hypertension and normotension. Collectively, these findings suggest that high blood pressure may induce lung inflammation via an ACE/ACE2 imbalance. BP control with either an RAS inhibitor or a calcium channel blocker rebalances RAS in SHR lungs and alleviates inflammation. Furthermore, this study provides a mechanistic link between inflammatory lung diseases (such as COVID-19) and hypertension as a major risk factor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renin-Angiotensin SystemLungLosartanBlood PressureHypertensionAmlodipineAntihypertensive AgentsAnimalsMaleRats, Inbred SHRAngiotensin-Converting Enzyme 2RatsAngiotensin IIHumansAngiotensin IPeptidyl-Dipeptidase APeptide Fragments

Stichwörter der Autor:innen

ACEACE2angiotensin iihypertensioninflammationlungs

Substanzen

Angiotensin-Converting Enzyme 2LosartanAmlodipineAntihypertensive AgentsAngiotensin IIAce2 protein, ratAngiotensin IPeptidyl-Dipeptidase Aangiotensin I (1-7)Peptide Fragments

Autor:innen und Institutionen

  • Laboratório de Genética e Cardiologia Molecular, Faculdade de Medicina, Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, Universidade de São Paulo, São Paulo, SP, Brazil.
  • Department of Ophthalmology and Visual Sciences, State University of New York (SUNY) Upstate Medical University, Syracuse, NY, USA.
  • Departmento de Patologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.
  • Unidade de Cardiogeriatria, Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
  • Academic Research Organization (ARO), Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
  • Divisão de Pneumologia, Faculdade de Medicina, Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, Universidade de São Paulo, São Paulo, SP, Brazil.

ORCID-Profile: Adriana C C Girardi

Förderung

  • NEI NIH HHS

Zitieren

APA

Braga, G. C. D., Ribeiro-Silva, J. C., Boaro, A., Martins, F. L., Mauad, T., Tavares, C. A. M., Teixeira, L. R., Caramelli, B., & Girardi, A. C. C. (2025). Restoring lung renin-angiotensin system balance through blood pressure control. Clinical Science, 139(03), 215-227. https://doi.org/10.1042/cs20241155

Vancouver

Braga GCD, Ribeiro-Silva JC, Boaro A, Martins FL, Mauad T, Tavares CAM, et al. Restoring lung renin-angiotensin system balance through blood pressure control. Clinical Science. 2025;139(03):215-227. doi:10.1042/cs20241155

BibTeX
@article{Braga2025,
  author = {Braga, Gabriela Catão D and Ribeiro-Silva, Joao Carlos and Boaro, Andreia and Martins, Flavia Leticia and Mauad, Thais and Tavares, Caio A M and Teixeira, Lisete Ribeiro and Caramelli, Bruno and Girardi, Adriana C C},
  title = {Restoring lung renin-angiotensin system balance through blood pressure control},
  journal = {Clinical Science},
  year = {2025},
  volume = {139},
  number = {03},
  pages = {215--227},
  doi = {10.1042/cs20241155}
}
Kostenlos starten →